Torrent Pharmaceuticals informs about press release

11 Jul 2019

Torrent Pharmaceuticals has informed that the Company and Glenmark Pharmaceuticals have signed licensing agreement for co-marketing of Remogliflozin Etabonate in India. A Press release, containing the transaction details, which is being submitted to the media is enclosed herewith for information and record.

The above information is a part of company’s filings submitted to BSE.

Related Torrent Pharmaceuticals Ltd. Links:

Torrent Pharma Share Price

2476.35 50.80 (2.09%) Feb 24, 18:55
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 602.55
Dr. Reddys Lab 4441.50
Lupin 1007.60
Piramal Enterprises 1858.80
Cadila Healthcare 433.90
View more..
Sensex vs Torrent Pharma
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback